Finally, we wrap up the belated April hires round-ups with our “pharma supplier” round-up inclusive of tech vendors, CROs, CDMOs, and others adjacent to the space. This is also where we mention ...
As the country looks to commercial companies to drive innovation, it has a golden opportunity to support open science and increase its output in key areas.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results